Find a Tender
complete
Official procurement procedure
UKRI-1161 Laser Micro-dissection Inverted Imaging System
For laboratory use
Laboratory
optical and precision equipments (excl. glasses)
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: UK Research & Innovation: "UKRI-1161 Laser Micro-dissection Inverted Imaging System". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | UK Research & Innovation | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: UK Research & Innovation
Market Analytics
Derived from OCDS awards & bid statistics
Published history for UK Research & Innovation. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 253 active published awards; 251 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUK Research & Innovation | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published20 Feb 2021, 09:32 GMT | Last source update20 Feb 2021, 09:32 GMT | Recurring procurementNot published |
ClassificationFor laboratory use, Laboratory, optical and precision equipments (excl. glasses) | ||
Delivery area UK | ||
OCIDocds-h6vhtk-0294b7 | ||
What is being bought
Supply of MMI Laser Microdissection Inverted Imaging System with the ability to measure the presence of the oligonucleotide-based drugs (i.e. antisense and siRNA) within the tissue and assess drug action through measurement of changes in the mRNA and protein levels of the drug target. We require a brightfield/fluorescence microscope that can be employed to view, record and quantify tissues stained by H&E, in situ hybrisation (ISH) and immunohistochemistry (IHC). We also require an attached laser that can be employed to provide tissue section down to the single cell level for the analysis of drug, mRNA and protein levels. In addition, we require a system that can be expanded in the future through the addition of a confocal microscope.
What changed
From the official release history
- Status changed to complete
20 Feb 2021, 09:32 GMT - Official notice release published
20 Feb 2021, 09:32 GMT - Buyer information updated
20 Feb 2021, 09:32 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedSupply of MMI Laser Microdissection Inverted Imaging System with the ability to measure the presence of the oligonucleotide-based drugs (i.e. antisense and siRNA) within the tissue and assess drug action through measurement of changes in the mRNA and protein levels of the drug target. We require a brightfield/fluorescence microscope that can be employed to view, record and quantify tissues stained by H&E, in situ hybrisation (ISH) and immunohistochemistry (IHC). We also require an attached laser that can be employed to provide tissue section down to the single cell level for the analysis of drug, mRNA and protein levels. In addition, we require a system that can be expanded in the future through the addition of a confocal microscope.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
20 Feb 2021, 09:32 GMT - Award active
Not published · Not published - Contract active
Signed 25 Jan 2021, 00:00 GMT · £228,115
Commercial outcome and competition
Awards Olympus (Uk) Ltd Not published · Not published · active |
Contracts Contract £228,115 · signed 25 Jan 2021, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
UK Research & Innovation
Contracting authority GB-FTS-1496Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThis system was chosen as it needed to integrate into current systems and equipment on site and was therefore the only option.
Only the Olympus MMI Laser Microdissection Inverted Imaging System has a modular system which allows the addition, integration and onboarding of these facilities such as confocal microscopy, live cell imaging and high content screening to provide a system that can deliver all of the following functions: live cell imaging, spinning disc confocal and high content screening, whilst retaining the original functionality of the system and without hardware replacement.
Also, we require a laser to micro-dissect single cells and tissue biopsies for quantifiable analysis such as RT-PCR, sequencing and western blotting. The sample capture procedure must be an upward capture system in order to reduce contamination of samples to a minimum. It must be possible to maintain an RNA-ase and DNA-ase free environment.
This is the only equipment able to deliver all the above as an integrated system. |